Cornelia F Allaart

12.7k citations

189 papers · 7.3k indexed · 2 hit papers · h-index 46

Rheumatology top 0.05%
- Rheumatoid Arthritis Research and Therapies 156
- Systemic Lupus Erythematosus Research 67
- Spondyloarthritis Studies and Treatments 18
- Musculoskeletal synovial abnormalities and treatments 14
Hematology top 0.2%
- Autoimmune and Inflammatory Disorders Research 46
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 37
Immunology top 2%
- Biosimilars and Bioanalytical Methods 12
Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment 37

Co-authors: T. Huizinga Ben A. C. Dijkmans P. J. S. M. Kerstens Jeska K de Vries‐Bouwstra H. K. Ronday Willem F. Lems Y P M Goekoop-Ruiterman J.H.L.M. van Groenendael
Cited by: Rheumatology Hematology Genetics
Journals: The Lancet (2 papers)SHILAP Revista de lepidopterología (1 paper)Annals of Internal Medicine (3 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Cornelia F Allaart

183 papers receiving 7.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Cornelia F Allaart

Since Specialization

Citations

This map shows the geographic impact of Cornelia F Allaart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia F Allaart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia F Allaart more than expected).

Fields of papers citing papers by Cornelia F Allaart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelia F Allaart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia F Allaart. The network helps show where Cornelia F Allaart may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Cornelia F Allaart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cornelia F Allaart Line = papers co-authored together Cornelia F Allaart links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Rheumatoid arthritis-associated interstitial lung disease in countries across the world Seminars in Arthritis and Rheumatism ·Sascha L Heckert,Tjardo Maarseveen,E.R. Marges,Arvind Chopra,David Vega‐Morales,R Du Toit,Lai Ling Winchow,Nimmisha Govind,Carlos Enrique Toro Gutiérrez,Rachel Knevel,Annette H M van der Helm–van Mil,T. Huizinga,Cornelia F Allaart,Sytske Anne Bergstra	2025	0
2	Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies Lara D. Veeken ·Sascha L Heckert,Johanna Maria Maassen,I. Nevins,Paul Baudoin,Gerda M. Steup‐Beekman,T. Huizinga,Sytske Anne Bergstra,Cornelia F Allaart	2024	4
3	Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time? Annals of the Rheumatic Diseases ·Lotte van Ouwerkerk,Patrick Verschueren,Maarten Boers,Paul Emery,Pascal H P de Jong,Robert Landewé,Willem F. Lems,Josef S Smolen,T. Huizinga,Cornelia F Allaart,Sytske Anne Bergstra	2023	3
4	Patterns of clinical joint inflammation in juvenile idiopathic arthritis RMD Open ·Sascha L Heckert,Petra C E Hissink-Muller,J. Merlijn van den Berg,Dieneke Schonenberg‐Meinema,Lisette W. A. van Suijlekom‐Smit,Marion A. J. van Rossum,Yvonne Koopman,R. ten Cate,D. M. C. Brinkman,T. Huizinga,Cornelia F Allaart,Sytske Anne Bergstra	2023	5
5	Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial Annals of the Rheumatic Diseases ·Abdullah Ali Hadi Almayali,Maarten Boers,Linda Hartman,Daniela Opriș-Belinski,Reinhard Bos,Marc R. Kok,José António Pereira da Silva,E. N. Griep,Ruth Klaasen,Cornelia F Allaart,Paul Baudoin,Hennie G. Raterman,Zoltán Szekanecz,Frank Buttgereit,P. Masaryk,Willem F. Lems,Yvo M. Smulders,Maurizio Cutolo,Marieke M. ter Wee	2023	9
6	Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysis Seminars in Arthritis and Rheumatism ·Lotte van Ouwerkerk,Sytske Anne Bergstra,Tjardo Maarseveen,T. Huizinga,Rachel Knevel,Cornelia F Allaart	2023	1
7	Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort Annals of the Rheumatic Diseases ·Sascha L Heckert,Johanna Maria Maassen,Saskia le Cessie,Y P M Goekoop-Ruiterman,Melek Güler-Yüksel,Willem F. Lems,T. Huizinga,Sytske Anne Bergstra,Cornelia F Allaart	2023	6
8	Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment RMD Open ·Sascha L Heckert,Sytske Anne Bergstra,Yvonne P M Goekoop-Ruiterman,Melek Güler-Yüksel,Willem F. Lems,X. Matthijssen,M. van Oosterhout,T. Huizinga,Cornelia F Allaart	2023	4
9	Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort RMD Open ·Sophie I E Liem,Jacopo Ciaffi,Nina M. van Leeuwen,Maaike Boonstra,Saad Ahmed,Liesbeth J J Beaart-van de Voorde,Anja Corsel,Talitha Dhondai,Maarten K. Ninaber,J J Miranda Geelhoed-Veltman,Marlies E. Heuvers,Maarten E. Tushuizen,Nina Ajmone Marsan,Philippine Kiès,Anne A. Schouffoer,T. Huizinga,Cornelia F Allaart,Jeska de Vries‐Bouwstra	2023	4
10	The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial Lara D. Veeken ·Sophie I E Liem,Eva M. Hoekstra,Femke Bonte‐Mineur,César Magro‐Checa,Anne A. Schouffoer,Cornelia F Allaart,T. Huizinga,Sytske Anne Bergstra,Jeska K de Vries‐Bouwstra	2022	2
11	IgG Anti–Citrullinated Protein Antibody Variable Domain Glycosylation Increases Before the Onset of Rheumatoid Arthritis and Stabilizes Thereafter: A Cross‐Sectional Study Encompassing ~1,500 Samples Arthritis & Rheumatology ·Theresa Kissel,Lise Hafkenscheid,Tineke J van Wesemael,Mami Tamai,Shin‐ya Kawashiri,Atsushi Kawakami,Hani El‐Gabalawy,Dirkjan van Schaardenburg,Solbritt Rantapää‐Dahlqvist,Manfred Wuhrer,Annette H M van der Helm–van Mil,Cornelia F Allaart,Diane van der Woude,Hans Ulrich Scherer,René E. M. Toes,T. Huizinga	2022	35
12	Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial Annals of the Rheumatic Diseases ·Maarten Boers,Linda Hartman,Daniela Opriș-Belinski,Reinhard Bos,Marc R. Kok,José António Pereira da Silva,Eduard N. Griep,Ruth Klaasen,Cornelia F Allaart,Paul Baudoin,Hennie G. Raterman,Zoltán Szekanecz,Frank Buttgereit,P. Masaryk,L Thomas Klausch,Sabrina Paolino,A. Schilder,Willem F. Lems,Maurizio Cutolo,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2022	83
13	Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis Annals of the Rheumatic Diseases ·Lotte van Ouwerkerk,Andriko Palmowski,Isabell S Nevins,Frank Buttgereit,Patrick Verschueren,Josef S Smolen,Robert Landewé,Johannes JW Bijlsma,Andreas Kerschbaumer,René Westhovens,T. Huizinga,Cornelia F Allaart,Sytske Anne Bergstra	2022	15
14	Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill count Lara D. Veeken ·Linda Hartman,Maurizio Cutolo,Reinhard Bos,Daniela Opriș-Belinski,Marc R. Kok,Hanneke R. M. Griep-Wentink,Ruth Klaasen,Cornelia F Allaart,George A. W. Bruyn,Hennie G. Raterman,Marieke Voshaar,Nuno Gomes,Rui M. A. Pinto,L Thomas Klausch,Willem F. Lems,Maarten Boers	2021	7
15	New risk model is able to identify patients with a low risk of progression in systemic sclerosis RMD Open ·Nina M. van Leeuwen,M. Maurits,Sophie I E Liem,Jacopo Ciaffi,Nina Ajmone Marsan,Maarten K. Ninaber,Cornelia F Allaart,Henrike Gillet van Dongen,Robbert J Goekoop,T. Huizinga,Rachel Knevel,Jeska de Vries‐Bouwstra	2021	4
16	Rheumatoid arthritis patients with continued low disease activity have similar outcomes over 10 years, regardless of initial therapy Lara D. Veeken ·Sytske Anne Bergstra,Robert Landewé,T. Huizinga,Cornelia F Allaart	2017	4
17	Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment Annals of Internal Medicine ·I.M. Markusse,G. Akdemir,Linda Dirven,Yvonne P M Goekoop-Ruiterman,J.H.L.M. van Groenendael,K. Huub Han,T.H.E. Molenaar,Saskia le Cessie,Willem F. Lems,Peter A. H. M. van der Lubbe,P. J. S. M. Kerstens,André J. Peeters,H. K. Ronday,P. B. J. de Sonnaville,I. Speyer,Theo Stijnen,S. ten Wolde,T. Huizinga,Cornelia F Allaart	2016	2
18	A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study Lara D. Veeken ·Shintaro Hirata,Linda Dirven,Yijing Shen,Michael Centola,G. Cavet,Willem F. Lems,Yoshiya Tanaka,T. Huizinga,Cornelia F Allaart	2013	70
19	Randomized Clinical Trial in Pediatric Rheumatology: Are Parents and Patients in Equipoise? Data Archiving and Networked Services (DANS) ·(unknown),Bülent Yıldız,Cornelia F Allaart,D. M. C. Brinkman,(unknown),J. Merlijn van den Berg,(unknown),R. ten Cate,Martine C. de Vries	2012	1
20	Remission Induction Therapy with Methotrexate and Prednisone in Patients with Early Rheumatoid and Undifferentiated Arthritis. Arthritis & Rheumatism ·K.V.C. Wevers-de Boer,L. Heimans,K. Visser,H. K. Ronday,T.H.E. Molenaar,Patrick Seys,C. Bijkerk,M L Westedt,W. de Beus,P.B. de Sonnaville,T. Huizinga,Cornelia F Allaart	2011	4

About Cornelia F Allaart

Cornelia F Allaart is a scholar working on Rheumatology, Hematology and Genetics, having authored 189 papers that have together received 7.3k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (156 papers), Systemic Lupus Erythematosus Research (67 papers), Autoimmune and Inflammatory Disorders Research (46 papers), Chronic Lymphocytic Leukemia Research (37 papers), Lymphoma Diagnosis and Treatment (37 papers), Spondyloarthritis Studies and Treatments (18 papers), Musculoskeletal synovial abnormalities and treatments (14 papers) and Biosimilars and Bioanalytical Methods (12 papers). The work is most often cited by research in Rheumatology (6.1k citations), Hematology (2.1k citations) and Genetics (1.3k citations). Cornelia F Allaart has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include T. Huizinga, Ben A. C. Dijkmans, P. J. S. M. Kerstens, Jeska K de Vries‐Bouwstra, H. K. Ronday, Willem F. Lems, Y P M Goekoop-Ruiterman, J.H.L.M. van Groenendael, F. C. Breedveld and K. H. Han. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact